MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mou.0000000000001292

Медицинская библиотека · Current opinion in urology · 2025

Biochemical recurrence after radical prostatectomy and postoperative radiotherapy: current evidence and controversial issues.

Longoni Mattia, Falkenbach Fabian, Graefen Markus, Maurer Tobias, Karakiewicz Pierre I, Montorsi Francesco, Briganti Alberto, Gandaglia Giorgio

СтатьяОбзорПеревод в очереди

Аннотация

PURPOSE OF REVIEW: This review explores challenges in managing biochemical recurrence (BCR) after radical prostatectomy and postoperative radiotherapy for prostate cancer (PCa) highlighting gaps in risk stratification, imaging, and emerging therapies, as well as advances in molecular imaging and personalized treatment.

RECENT FINDINGS: Approximately half of PCa patients experience a second BCR after postoperative radiotherapy. Time to recurrence, PSA kinetics, adverse pathological features (ISUP 4-5, pT3-4, and positive surgical margins), alongside genetic profile, are key factors for risk stratification. Combination of androgen deprivation therapy (ADT) and novel androgen receptor pathway inhibitors (ARPIs) represents an established treatment choice. However, recent findings emphasize the growing role of prostate-specific membrane antigen (PSMA) PET in detecting recurrent disease and guide tailored strategies. Based on early phase II trials and retrospective studies, metastasis-directed therapy (MDT) has demonstrated promising efficacy in oligorecurrent PCa, although further validation is warranted.

SUMMARY: BCR after radical prostatectomy and postoperative radiotherapy represents a challenge in PCa management. Risk stratification is key for guiding the addition of ARPIs to standard ADT. PSMA PET may further refine tailored strategies such as MDT, whose promising efficacy needs further exploration. Ongoing trials will clarify treatment sequencing and patient selection in the evolving paradigm of BCR management.

Для цитирования: Longoni Mattia, Falkenbach Fabian, Graefen Markus, Maurer Tobias, Karakiewicz Pierre I, Montorsi Francesco, Briganti Alberto, Gandaglia Giorgio. Biochemical recurrence after radical prostatectomy and postoperative radiotherapy: current evidence and controversial issues.. Current opinion in urology. 2025. DOI: 10.1097/mou.0000000000001292.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.